On the basis of confirmation received from its Registrar and Transfer Agent, Kfin Technologies (formerly known as Kfin Technologies), Procter & Gamble Health has confirmed that the details of securities dematerialised during the quarter ended September 30, 2024 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished to the stock exchanges where the shares of the Company are listed within the prescribed time period. The company has enclosed the copy of letter received from Kfin Technologies confirming the above.
The above information is a part of company’s filings submitted to BSE.
